<?xml version='1.0' encoding='UTF-8'?><metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns="http://dublincore.org/documents/dcmi-terms/"><dcterms:title>HVTN 302 immunogenicity + safety manuscript (Science Translational Medicine)</dcterms:title><dcterms:identifier>https://doi.org/10.7910/DVN/Y8OC5L</dcterms:identifier><dcterms:creator>HIV Vaccine Trial Network Statistics and Data Management Center</dcterms:creator><dcterms:publisher>Harvard Dataverse</dcterms:publisher><dcterms:issued>2025-07-15</dcterms:issued><dcterms:modified>2025-07-17T17:13:55Z</dcterms:modified><dcterms:description>This dataset is in support of a pending publication in Science Translational Medicine. A full citation will be added when the manuscript is published.</dcterms:description><dcterms:subject>Medicine, Health and Life Sciences</dcterms:subject><dcterms:subject>HIV-1</dcterms:subject><dcterms:subject>Clinical trial, phase 1</dcterms:subject><dcterms:subject>Humans</dcterms:subject><dcterms:subject>HIV vaccines</dcterms:subject><dcterms:subject>mRNA vaccines</dcterms:subject><dcterms:date>2025-07-15</dcterms:date><dcterms:contributor>HVTN SDMC</dcterms:contributor><dcterms:dateSubmitted>2025-04-22</dcterms:dateSubmitted><dcterms:license>CC BY-NC-ND 4.0</dcterms:license></metadata>